Brief: BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing
30/10/2025 11:20
Oct 30 (Reuters) - BioXcel Therapeutics Inc BTAI.O: BIOXCEL THERAPEUTICS INC - UPDATES ON SNDA SUBMISSION FOR IGALMI LABEL EXPANSION - SEC FILING BIOXCEL THERAPEUTICS INC - EXPECTS SNDA SUBMISSION COMPLETION EARLY Q1 2026 - SEC FILING Source text: [ID:n0001104659-25-104009] Further company coverage: BTAI.O (Reporting by Anhata Rooprai) ((Anhata.Rooprai@thomsonreuters.com;))
Recent news on BioXcel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna
Brief: Bioxcel Therapeutics Enters Into Asset Sale Agreement With Teva Pharmaceuticals
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta Beauty